Suzhou Kintor Pharmaceutical Inc,   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Suzhou China (2009)

Organization Overview

First Clinical Trial
2016
NCT02826772
First Marketed Drug
2018
metoprolol (lopressor)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Suzhou Kintor Pharmaceutical Inc, | Suzhou Kintor Pharmaceuticals,inc | Suzhou Kintor Pharmaceuticals,inc. | Suzhou Kintor Pharmaceuticals Inc | Suzhou Kintor Pharmaceuticals Inc. | VISUM PHARM